Bausch + Lomb Announces Third-Quarter 2022 Results

Third-Quarter 2022 Financial Results Revenues of $942 Million GAAP Net Loss Attributable to Bausch + Lomb Corporation of $18 Million Adjusted EBITDA...

Related Keywords

China ,Italy ,Josephc Papa , ,Ophthalmic Pharmaceuticals ,Walmart ,Foreign Exchange Negatively Impacted Revenues ,Health Care Products For ,Drug Administration ,Lomb Corporation ,Ophthalmic Pharmaceuticals Segment ,Loss Attributable ,Third Quarter ,Quarter Reported Revenues Declined ,Growth Across All ,Exchange Negatively Impacted Revenues ,Year Revenue ,Primarily Due ,New Drug Application ,Enhanced Ocuvite ,Alfa Instruments ,Alfa Instrument ,Project Watson ,Health Care Products ,Sanoculi Minimally Invasive Micro Sclerostomy ,Months Ended ,